颤三针为主治疗帕金森病的临床与实验研究
|
摘要
帕金森病是一种常见的中老年人神经系统变性疾病,具有高发病率、高致残率的特点。有资料显示,50岁以上的发病率为500/10万人口,60岁以上则明显增加,为1000/10万人口。帕金森病在发病的10到15年内可以导致老年病人明显的残障。随着社会人口的老龄化,帕金森病的发病率正逐年增高,且有年轻化的趋势。帕金森病是继脑血管病之后,中老年人最为常见的一种病症,它严重的危害中老年人的身体健康和生活质量,给社会和家庭造成巨大的经济负担和精神压力。
作为21世纪神经科学重要的研究疾病之一,帕金森病(PD)目前尚无办法根治,且早期诊断率较低,各种客观诊断和检测指标还在研究当中、尚不成熟。当前PD治疗的目的主要在于控制临床症状,尽可能的维持病人独立的生活能力和良好的生活质量。尽管通过药物为主的内科治疗,在一定程度上可以有效地使PD患者控制病情、缓解症状和延缓病程,但是长期用药后,患者容易出现各种毒副作用和并发症,如剂末现象、开关现象、不自主的异动症、恶心、呕吐等,导致很多病人最后无法坚持治疗。为了减小西药毒副作用、增强临床疗效,目前人们越来越重视中医和针灸的治疗方法。临床资料显示针灸在治疗PD方面是行之有效的一种方法,但是目前国内外在此方面的研究却相对较少。
导师靳瑞教授所创立的“颤三针”疗法是在几十年治疗脑病的临床基础上总结而出的,它是以“四神针”为主的一组穴位,在临床治疗帕金森病中已经应用多年,且临床疗效显著。已有的工作基础表明运用“颤三针”治疗帕金森病具有明显的止颤作用,在减轻患者的临床症状、减少西药的毒副作用和并发症方面具有独特的效果。本课题就是在此基础上提出并进行研究的。
本文系统研究了针灸、中医及现代医学文献对帕金森病(老年颤证)的认识和研究进展,对颤三针治疗帕金森病从临床和实验两方面进行了研究。
目的:通过随机对照的临床研究方法,客观评价颤三针疗法对帕金森病(PD)的疗效;同时利用动物PD模型,初步探讨“颤三针”疗法治疗帕金森病(PD)的机理,进一步验证“靳三针”疗法在治疗脑病方面的科学性和实用性。
内容:本研究采用多学科先进研究方法和观察指标,对应用颤三针疗法治疗帕金森病的疗效和作用机理进行系统的前瞻性研究。在严格按照临床研究设计的基础上,对符合纳入标准的PD患者进行临床观察,通过目前世界公认的UPDRS评分法,计算病人治疗前后的各项相关积分,来观察应用颤三针疗法治疗PD患者的疗效。为临床寻找一种较安全有效而副作用小的临床治疗方法,提高PD患者的生活质量,降低这一高发疑难疾病的致残率,进一步验证“靳三针”疗法治疗脑病的疗效及其作用机制。
方法:临床研究,参照1984年全国锥体外系疾病讨论会所定的帕金森病(PD)诊
Parkinson's disease has become one kind of nervous system denatured disease in middle-aged and old people commonly, and it has the characteristic of high disease incidence and high crippling rate. Some data display that it has a disease incidence of 500 per 100 thousand population in age more than 50 years , and 1000 per 100 thousand population in age more than 60 years which increases obviously. The parkinson' s disease can induce obvious handicap when old people get sick in 10 to 15 years. Following social population aging, the disease incidence of parkinson is advancing year by year, and also has a tendency of juvenescence. Parkinson's disease is the most common disease in middle-aged and old people besides the cerebrovascular disease at present, which does harm to health and quality of life in middle-aged and old people seriously, bringing a huge economical burden and stress for society and family.As one of important researching diseases of neuroscience in the 21st century, parkinson's disease(PD) still did not have the means to be radical cured at present, and the pristine diagnose rate is very low, various kinds of objective diagnosis and the detected index are to be researched, which are still not mature. The medicative goal of PD mainly lies in controlling clinical symptom, maintaining patient' s independent viability and good quality of life as far as possible at present. Although through the medical treatment mainly in drugs can make the PD patient's condition to be controlled effectively , relieving symptom and delaying course in the certain degree, but after long-term medication, the patients are easy to appear various kinds of toxical side effect and complication, e. g. dosage telophase phenomenon, switch-open phenomenon and heteronomous abnormal motion, nausea, vomito and so on, in the end many patients are unable to persist in treating. In order to reduce toxical
side effect of western medicine and enhance clinical curative effect, at present people more and more think highly of the treatment with Chinese medicine and the therapy of acupuncture and moxibustion. The clinical data demonstrated that acupuncture and moxibustion was a effective method in treating PD disease, but now relative researches are actually few in this aspect domestic and abroad.Tutor Pro. Jinrui established a therapy of "trembling-three needles" to treat PD disease, which based on the clinical foundation of treating cerebral disease in several dozens years, and it is a group of acupoints primary in "mind-four needles" , being already used many years in the clinical treatment for parkinson' s disease, also it had a striking curative effect in clinic. The work foundation indicated that the therapy of "trembling-three needles" had a obvious function to stop tremble in treating parkinson's disease, and it had a distinct effect in reducing patient's clinical symptom, lessening toxical side effect of western medicine and complication. This topic was proposed and studied from the foundation.This article had studied the literature of acupuncture and moxibustion, Chinese medicine and modern medicine in cognition and research progress systematically to parkinson' s disease (old people trembling), undertaking the clinical and experimental study on treating parkinson's disease with trembling-three needles.Objective: Through the clinical research method at random and comparison, evaluating the curative effect of trembling-three needles to treat parkinson' s disease (PD) objectively-, at the same time using the animals model of PD, discussing the mechanism preliminary on the therapy of "trembling-three needles" to treat parkinson's disease (PD), further confirming scientific nature and usability about the therapy of "Jin-three needles" to treat the cerebral disease.Contents: This research used multidisciplinary advanced methods and observed index to carry out a systematic and prospective study on the curative effect and the mechanism of action which used therapy of trembling-three needles to treat parkinson disease. According to foundation of the clinical research designed strictly, carrying on the clinical observation of PD patients which are in line with the standard of internalization, through the UPDRS integration accepted universally at present, calculating patient' s each
correlation integral of pretherapy and post-treatment, observing the curative effect of utilizing therapy of trembling-three needles to treat PD patients. For seeking one kind of safely-effective clinical method and diminishing the side effect, improving the PD patient' s quality of life, reducing the crippling rate of this high incidence and difficult disease, in order to confirm the the curative effect and its functional mechanism of Jin-three needles therapy in treating cerebral disease.Methods: The clinical research, refering to the diagnostic criteria of parkinson disease(PD) which instituted in 1984 by the conference of extracorticospinal tract diseases, choosing 68 parkinsons patients which consistent with the diagnose and internalized standard, according to Hoehn and Yahr revised stage and divided patient' s condition into light degree, midrange, heavy degree (0 to 1. 5 stage is light degree;2 to 3 stage is midrange;fourth, fifth stage is heavy degree), making manufacture stochastic cards, according to the laminar-stochastic method we divide the patients into trembling-three needles group for 35 cases, control group (taking medicine of Madopar primary) for 33 cases, two groups were all maintained the fundamental treatment with western medicine. The main acupoints of the trembling-three needles group was: Trembling-three needles (mind-four needles, siguan points and fengchi);Siguan acupoints were hegu and taichong bilateralis. Dialectical acupoints: yin-deficiency of Liver and kidney can add ganshu, shenshu and sanyinjiao;phlegm and heat lead to wind can add f englong, zhongwan, yinlingquan;insufficiency of vital energy and blood can add qihai, xuehai, zusanli. symptomatic acupoints: agrypnia patients can add dingshen needles, shouzhi needles;costive patients can add intestine-three needles;depressed people can add wisdom-three needles;nocturia patients can add yang-three needles. Every time of the acupuncture is 60 minutes, manipulating needle every 20 minutes, needling one time every other day, and a course of treatment is 15 times, observing two course of treatment continuously. In control group patients took medicine Madopar and so on, the dosage was decided by patient' s condition and individual difference. Observed index.- evaluating the unified parkinson' s disease rating scale (UPDRS), according to UPDRS we calculated the progressive rate of depression, sleep disorder, tremble inactivity, posture barrier, muscular rigidity, language and deglutation after the treatment. We carried on evaluating them separately during pretherapy and post-treatment,
then carried out statistical analysis for testing results.Experimental study: The models of PD were established through the method of two points injecting 6-hydroxydopa(6-OHDA). Choosing 46 healthy male SD-rats in SPF level, among the total was experimental group for 30 rats, Physiological saline control group for 8, normal blank control group for 8. In the end it was 27 rats succeed in PD model after inducing by APO, so we divided them into three groups at random: model group for 9, western medicine treatment group (intragastric administration by Madopar) for 9, acupuncture treatment group for 9. Handling measurement: In normal blank control group, only grasping rats with hands but did not given any treament to them;in model group and physiological saline control group we made them recovery by themselves, in western medicine treatment group we given intragastric administration by Madopar to the rats (dosage of 240mg per kilogram, equivalent 7 times to the people's concentration), one time everyday;in acupuncture treatment group we choosed baihui, hegu and taichong bilateralis to treat them, their allocation refered to the acupoints of rats. Treatment methods: Using number 30 and 1 cun length stainless steel acupuncture needle prick into baihui point deep in 0. 5 cun sparallelled, pricking into hegu and taichong point deep in 0. 5 cun perpendicularly, using the chirismus of rolling and extract-insert method, acupuncture treatment one time everyday, staying needle 30 minutes each time, manipulating needle one time per 5 minutes. The time of therapy of each group are all 2 months, when the time of therapy had completed we would take out of 2 rats from each group to make the pathological section at random and to make the morphology observation. At the same time we decapitated to kill the surplus rats, taking out left side of the cerebral nigra to detect activity of superoxide dismutase(SOD) and nitrogen monoxidum(NO), comparing the results of each groups and carrying on statistics analysis.Results:Clinical research: 1. Before treatment, trembling-three needles group and control group did not have statistics difference (P>0. 05) in total UPDRS score, and each part of grades for I, II, III, IV, so they had comparability. After treatment trembling-three needles group can reduce total UPDRS score and each part of grades remarkably (P<0.01), control group also improve total UPDRS score, I, II, III, IV parts (P<0.05);curative effect of trembling-three needles group was surpassed obviously to control group on treating parkinson
disease (P<0.05). It showed that the therapy of "trembling-three needles" had a remarkable effect to improve the motor symptoms of PD, enhancing the quality of life, eliminate complication of western medicine, moreover this kind of curative effect prominently lay in improving patient's emotion and daily life ability. After treatment two groups had a remarkable enhancement in progresses rate (P<0.01);compared with control group, trembling-three needles group had a extremely remarkable difference in improving depression, dyssomnia, static tremorthe, language and deglutition (P<0.01);also it had a obvious effect to improve clinical symptoms e. g. motion, posture barrier and myotonia (P<0. 05). It explained trembling-three needles group had a good effect to stop tremble, and had a extremely remarkable effect to depression, sleeping, speaking and deglutation in PD patients, which was superior to the motor function improved. Experimental study: in model group dopamine(DA) neuron solidified, analosis, apoptosis massive;in acupuncture and the western medicine group can cause the DA neuron increasing massive, but western medicine group had a obvious superiority, this possible because of the acupuncture time was too short. In normal blank control group and physiological saline group neuron did not be changed. Acupuncture treatment group and western medicine treatment group can elevated SOD and reduce the NO activity obviously, displaying acupuncture and western medicine treatment can increase the ability of antioxidase in rats, eliminating free radical;SOD and NO contents can droped obviously in model group, it showed that the method of 6-OHDA chemistry damaging can cause the nigral dopamine neuron denatured death massively,-Acupuncture treatment can improve PD rats clinical symptoms enormously, and had suppresses a function to restrain neuron apoptosis.Conclusion: l.The study discovered the therapy of "trembling-three needles" can enhance the PD patient's motor function remarkably, improving their daily life ability, alleviating complication of western medicine treatment effectively, and also this kind of curative effect mainly in relieving pressure of spirit and emotion, improving the function of autonomic nerve. 2. Experimental study discovered acupuncture can restrain DA neuron apoptosis effectively, increasing DA neuron quantity obviously, protecting the nigral neuron from denatured necrosis. 3. Acupuncture can strengthen SOD activity remarkably and reduce NO vigor, increasing the anti- oxidized ability, protecting PDrats brain from attacking and damage by the oxygen free radical.
Trembling-three needles is one of essence in the therapy "Jin-three needles" , as a experienced-effective point which my tutor summarized when he had treated parkinson disease in clinic for many years, and it had accurate curative effect to treat parkinson disease. Using trembling-three needles to treat parkinson disease can improve the emotion behavior of patients obviously, and enhance the quality of life, reduce the medicine treatment complication, also have a remarkable curative effect of stopping trembles. Moreover the therapy had a good function to treating and adjusting the motor symptoms and three accessory symptoms (constipation, nocturia and agrypnia) of PD, also it had a very good treatment and control action to depression, sleeping, walking, writing, debilitation, aches, anxious and so on. This conclusion appraised curative effect of acupuncture treatment in PD by the objective angle for the first time, the effect of acupuncture treatment mainly in improving symptoms, delaying the course of disease, raising the patient' s quality of life, reducing western medicine amount and the side effect, enhancing constitution and disease-resistant ability. Because acupuncture had a bilateral accommodation function to the human body, it did not have the obvious side effect, so it can be long-term used. For this reason, we believed acupuncture treatment had certain curative effect to PD, and it was a positive method to treat and rehabil PD. Experimental study results indicated that trembling-three needles therapy had a reliable curative effects, it is safe, non-toxic side effect, being worthy to generalization in clinical practice. Experimental study demonstrated trembling-three needles can achieve a therapeutic action as western medicine, the acupuncture' s function was possibly to strengthen the anti-oxidized ability, clear free radical, depress DA neuron apoptosis, these mechanism may be play a role to treat PD.This experiment had proven that Jin-three needles therapy had special effect in treating cerebral disease from many systems and many angles, establishment of trembling-three needles therapy was a abundance and development for "Jin-three needles" therapy.
作为21世纪神经科学重要的研究疾病之一,帕金森病(PD)目前尚无办法根治,且早期诊断率较低,各种客观诊断和检测指标还在研究当中、尚不成熟。当前PD治疗的目的主要在于控制临床症状,尽可能的维持病人独立的生活能力和良好的生活质量。尽管通过药物为主的内科治疗,在一定程度上可以有效地使PD患者控制病情、缓解症状和延缓病程,但是长期用药后,患者容易出现各种毒副作用和并发症,如剂末现象、开关现象、不自主的异动症、恶心、呕吐等,导致很多病人最后无法坚持治疗。为了减小西药毒副作用、增强临床疗效,目前人们越来越重视中医和针灸的治疗方法。临床资料显示针灸在治疗PD方面是行之有效的一种方法,但是目前国内外在此方面的研究却相对较少。
导师靳瑞教授所创立的“颤三针”疗法是在几十年治疗脑病的临床基础上总结而出的,它是以“四神针”为主的一组穴位,在临床治疗帕金森病中已经应用多年,且临床疗效显著。已有的工作基础表明运用“颤三针”治疗帕金森病具有明显的止颤作用,在减轻患者的临床症状、减少西药的毒副作用和并发症方面具有独特的效果。本课题就是在此基础上提出并进行研究的。
本文系统研究了针灸、中医及现代医学文献对帕金森病(老年颤证)的认识和研究进展,对颤三针治疗帕金森病从临床和实验两方面进行了研究。
目的:通过随机对照的临床研究方法,客观评价颤三针疗法对帕金森病(PD)的疗效;同时利用动物PD模型,初步探讨“颤三针”疗法治疗帕金森病(PD)的机理,进一步验证“靳三针”疗法在治疗脑病方面的科学性和实用性。
内容:本研究采用多学科先进研究方法和观察指标,对应用颤三针疗法治疗帕金森病的疗效和作用机理进行系统的前瞻性研究。在严格按照临床研究设计的基础上,对符合纳入标准的PD患者进行临床观察,通过目前世界公认的UPDRS评分法,计算病人治疗前后的各项相关积分,来观察应用颤三针疗法治疗PD患者的疗效。为临床寻找一种较安全有效而副作用小的临床治疗方法,提高PD患者的生活质量,降低这一高发疑难疾病的致残率,进一步验证“靳三针”疗法治疗脑病的疗效及其作用机制。
方法:临床研究,参照1984年全国锥体外系疾病讨论会所定的帕金森病(PD)诊
Parkinson's disease has become one kind of nervous system denatured disease in middle-aged and old people commonly, and it has the characteristic of high disease incidence and high crippling rate. Some data display that it has a disease incidence of 500 per 100 thousand population in age more than 50 years , and 1000 per 100 thousand population in age more than 60 years which increases obviously. The parkinson' s disease can induce obvious handicap when old people get sick in 10 to 15 years. Following social population aging, the disease incidence of parkinson is advancing year by year, and also has a tendency of juvenescence. Parkinson's disease is the most common disease in middle-aged and old people besides the cerebrovascular disease at present, which does harm to health and quality of life in middle-aged and old people seriously, bringing a huge economical burden and stress for society and family.As one of important researching diseases of neuroscience in the 21st century, parkinson's disease(PD) still did not have the means to be radical cured at present, and the pristine diagnose rate is very low, various kinds of objective diagnosis and the detected index are to be researched, which are still not mature. The medicative goal of PD mainly lies in controlling clinical symptom, maintaining patient' s independent viability and good quality of life as far as possible at present. Although through the medical treatment mainly in drugs can make the PD patient's condition to be controlled effectively , relieving symptom and delaying course in the certain degree, but after long-term medication, the patients are easy to appear various kinds of toxical side effect and complication, e. g. dosage telophase phenomenon, switch-open phenomenon and heteronomous abnormal motion, nausea, vomito and so on, in the end many patients are unable to persist in treating. In order to reduce toxical
side effect of western medicine and enhance clinical curative effect, at present people more and more think highly of the treatment with Chinese medicine and the therapy of acupuncture and moxibustion. The clinical data demonstrated that acupuncture and moxibustion was a effective method in treating PD disease, but now relative researches are actually few in this aspect domestic and abroad.Tutor Pro. Jinrui established a therapy of "trembling-three needles" to treat PD disease, which based on the clinical foundation of treating cerebral disease in several dozens years, and it is a group of acupoints primary in "mind-four needles" , being already used many years in the clinical treatment for parkinson' s disease, also it had a striking curative effect in clinic. The work foundation indicated that the therapy of "trembling-three needles" had a obvious function to stop tremble in treating parkinson's disease, and it had a distinct effect in reducing patient's clinical symptom, lessening toxical side effect of western medicine and complication. This topic was proposed and studied from the foundation.This article had studied the literature of acupuncture and moxibustion, Chinese medicine and modern medicine in cognition and research progress systematically to parkinson' s disease (old people trembling), undertaking the clinical and experimental study on treating parkinson's disease with trembling-three needles.Objective: Through the clinical research method at random and comparison, evaluating the curative effect of trembling-three needles to treat parkinson' s disease (PD) objectively-, at the same time using the animals model of PD, discussing the mechanism preliminary on the therapy of "trembling-three needles" to treat parkinson's disease (PD), further confirming scientific nature and usability about the therapy of "Jin-three needles" to treat the cerebral disease.Contents: This research used multidisciplinary advanced methods and observed index to carry out a systematic and prospective study on the curative effect and the mechanism of action which used therapy of trembling-three needles to treat parkinson disease. According to foundation of the clinical research designed strictly, carrying on the clinical observation of PD patients which are in line with the standard of internalization, through the UPDRS integration accepted universally at present, calculating patient' s each
correlation integral of pretherapy and post-treatment, observing the curative effect of utilizing therapy of trembling-three needles to treat PD patients. For seeking one kind of safely-effective clinical method and diminishing the side effect, improving the PD patient' s quality of life, reducing the crippling rate of this high incidence and difficult disease, in order to confirm the the curative effect and its functional mechanism of Jin-three needles therapy in treating cerebral disease.Methods: The clinical research, refering to the diagnostic criteria of parkinson disease(PD) which instituted in 1984 by the conference of extracorticospinal tract diseases, choosing 68 parkinsons patients which consistent with the diagnose and internalized standard, according to Hoehn and Yahr revised stage and divided patient' s condition into light degree, midrange, heavy degree (0 to 1. 5 stage is light degree;2 to 3 stage is midrange;fourth, fifth stage is heavy degree), making manufacture stochastic cards, according to the laminar-stochastic method we divide the patients into trembling-three needles group for 35 cases, control group (taking medicine of Madopar primary) for 33 cases, two groups were all maintained the fundamental treatment with western medicine. The main acupoints of the trembling-three needles group was: Trembling-three needles (mind-four needles, siguan points and fengchi);Siguan acupoints were hegu and taichong bilateralis. Dialectical acupoints: yin-deficiency of Liver and kidney can add ganshu, shenshu and sanyinjiao;phlegm and heat lead to wind can add f englong, zhongwan, yinlingquan;insufficiency of vital energy and blood can add qihai, xuehai, zusanli. symptomatic acupoints: agrypnia patients can add dingshen needles, shouzhi needles;costive patients can add intestine-three needles;depressed people can add wisdom-three needles;nocturia patients can add yang-three needles. Every time of the acupuncture is 60 minutes, manipulating needle every 20 minutes, needling one time every other day, and a course of treatment is 15 times, observing two course of treatment continuously. In control group patients took medicine Madopar and so on, the dosage was decided by patient' s condition and individual difference. Observed index.- evaluating the unified parkinson' s disease rating scale (UPDRS), according to UPDRS we calculated the progressive rate of depression, sleep disorder, tremble inactivity, posture barrier, muscular rigidity, language and deglutation after the treatment. We carried on evaluating them separately during pretherapy and post-treatment,
then carried out statistical analysis for testing results.Experimental study: The models of PD were established through the method of two points injecting 6-hydroxydopa(6-OHDA). Choosing 46 healthy male SD-rats in SPF level, among the total was experimental group for 30 rats, Physiological saline control group for 8, normal blank control group for 8. In the end it was 27 rats succeed in PD model after inducing by APO, so we divided them into three groups at random: model group for 9, western medicine treatment group (intragastric administration by Madopar) for 9, acupuncture treatment group for 9. Handling measurement: In normal blank control group, only grasping rats with hands but did not given any treament to them;in model group and physiological saline control group we made them recovery by themselves, in western medicine treatment group we given intragastric administration by Madopar to the rats (dosage of 240mg per kilogram, equivalent 7 times to the people's concentration), one time everyday;in acupuncture treatment group we choosed baihui, hegu and taichong bilateralis to treat them, their allocation refered to the acupoints of rats. Treatment methods: Using number 30 and 1 cun length stainless steel acupuncture needle prick into baihui point deep in 0. 5 cun sparallelled, pricking into hegu and taichong point deep in 0. 5 cun perpendicularly, using the chirismus of rolling and extract-insert method, acupuncture treatment one time everyday, staying needle 30 minutes each time, manipulating needle one time per 5 minutes. The time of therapy of each group are all 2 months, when the time of therapy had completed we would take out of 2 rats from each group to make the pathological section at random and to make the morphology observation. At the same time we decapitated to kill the surplus rats, taking out left side of the cerebral nigra to detect activity of superoxide dismutase(SOD) and nitrogen monoxidum(NO), comparing the results of each groups and carrying on statistics analysis.Results:Clinical research: 1. Before treatment, trembling-three needles group and control group did not have statistics difference (P>0. 05) in total UPDRS score, and each part of grades for I, II, III, IV, so they had comparability. After treatment trembling-three needles group can reduce total UPDRS score and each part of grades remarkably (P<0.01), control group also improve total UPDRS score, I, II, III, IV parts (P<0.05);curative effect of trembling-three needles group was surpassed obviously to control group on treating parkinson
disease (P<0.05). It showed that the therapy of "trembling-three needles" had a remarkable effect to improve the motor symptoms of PD, enhancing the quality of life, eliminate complication of western medicine, moreover this kind of curative effect prominently lay in improving patient's emotion and daily life ability. After treatment two groups had a remarkable enhancement in progresses rate (P<0.01);compared with control group, trembling-three needles group had a extremely remarkable difference in improving depression, dyssomnia, static tremorthe, language and deglutition (P<0.01);also it had a obvious effect to improve clinical symptoms e. g. motion, posture barrier and myotonia (P<0. 05). It explained trembling-three needles group had a good effect to stop tremble, and had a extremely remarkable effect to depression, sleeping, speaking and deglutation in PD patients, which was superior to the motor function improved. Experimental study: in model group dopamine(DA) neuron solidified, analosis, apoptosis massive;in acupuncture and the western medicine group can cause the DA neuron increasing massive, but western medicine group had a obvious superiority, this possible because of the acupuncture time was too short. In normal blank control group and physiological saline group neuron did not be changed. Acupuncture treatment group and western medicine treatment group can elevated SOD and reduce the NO activity obviously, displaying acupuncture and western medicine treatment can increase the ability of antioxidase in rats, eliminating free radical;SOD and NO contents can droped obviously in model group, it showed that the method of 6-OHDA chemistry damaging can cause the nigral dopamine neuron denatured death massively,-Acupuncture treatment can improve PD rats clinical symptoms enormously, and had suppresses a function to restrain neuron apoptosis.Conclusion: l.The study discovered the therapy of "trembling-three needles" can enhance the PD patient's motor function remarkably, improving their daily life ability, alleviating complication of western medicine treatment effectively, and also this kind of curative effect mainly in relieving pressure of spirit and emotion, improving the function of autonomic nerve. 2. Experimental study discovered acupuncture can restrain DA neuron apoptosis effectively, increasing DA neuron quantity obviously, protecting the nigral neuron from denatured necrosis. 3. Acupuncture can strengthen SOD activity remarkably and reduce NO vigor, increasing the anti- oxidized ability, protecting PDrats brain from attacking and damage by the oxygen free radical.
Trembling-three needles is one of essence in the therapy "Jin-three needles" , as a experienced-effective point which my tutor summarized when he had treated parkinson disease in clinic for many years, and it had accurate curative effect to treat parkinson disease. Using trembling-three needles to treat parkinson disease can improve the emotion behavior of patients obviously, and enhance the quality of life, reduce the medicine treatment complication, also have a remarkable curative effect of stopping trembles. Moreover the therapy had a good function to treating and adjusting the motor symptoms and three accessory symptoms (constipation, nocturia and agrypnia) of PD, also it had a very good treatment and control action to depression, sleeping, walking, writing, debilitation, aches, anxious and so on. This conclusion appraised curative effect of acupuncture treatment in PD by the objective angle for the first time, the effect of acupuncture treatment mainly in improving symptoms, delaying the course of disease, raising the patient' s quality of life, reducing western medicine amount and the side effect, enhancing constitution and disease-resistant ability. Because acupuncture had a bilateral accommodation function to the human body, it did not have the obvious side effect, so it can be long-term used. For this reason, we believed acupuncture treatment had certain curative effect to PD, and it was a positive method to treat and rehabil PD. Experimental study results indicated that trembling-three needles therapy had a reliable curative effects, it is safe, non-toxic side effect, being worthy to generalization in clinical practice. Experimental study demonstrated trembling-three needles can achieve a therapeutic action as western medicine, the acupuncture' s function was possibly to strengthen the anti-oxidized ability, clear free radical, depress DA neuron apoptosis, these mechanism may be play a role to treat PD.This experiment had proven that Jin-three needles therapy had special effect in treating cerebral disease from many systems and many angles, establishment of trembling-three needles therapy was a abundance and development for "Jin-three needles" therapy.
引文
[1] 隆呈祥整理.中医老年颤证诊断和疗效评定标准[J].北京中医学院学报,1992;15(4):39.
[2] 王克勤.震额麻痹的中医治疗[J].中医药研究,1991;(2):35.
[3] 李庚和.中医为主治疗震颤麻痹症50例临床分析[J].上海中医药杂志,1992;(2):12.
[4] 刘明武.震额麻痹辩治探幽[J].辽宁中医杂志,1997;(24):491.
[5] 王永炎,李明富,戴锡孟,等编.中医内科学[M],上海:上海科学技术出版社,1994,第6版:370.
[6] 王亚丽.颤证的病因病机探讨[J].陕西中医学院学报,1998;21(3):5.
[7] 朱红梅.震颤麻痹的病理探析[J].厦门大学学报·自然科学版,2000;(64):556-559.
[8] 邹忆怀.王永炎教授治疗颤振病(帕金森氏病)经验探讨[J].北京中医药大学学报,1996;(19):15.
[9] 隆呈祥.老年颤证(帕金森病)的中医研究回顾与展望[J].中国中医药信息杂志,2000;7(10):10—12.
[10] 武继涛.震颤麻痹从脾论治[J].浙江中医杂志,2003;38(9):399.
[11] 王一德.帕金森综合征的中医辨治[J].安徽中医学院学报,1997;16(3):42—43.
[12] 何建成.帕金森病中医药治疗的再思考——兼谈“滋肾平肝,化痰活血,解毒散结”是帕金森病的基本治疗法则[J].中医药通报,2005;4(1):12—14.
[13] 老膺荣,朱泉.帕金森氏病中医思辨[J].辽宁中医杂志,2005;32(10):1015—1016.
[14] 董洪涛.《内经》对颤症的认识[J].国医论坛,1998;13(3):17.
[15] 邢诒刚,陶恩祥.帕金森病[M],广州:广东高等教育出版社,1988,74.
[16] 樊銮.周仲英治疗震颤麻痹的经验[J].中医杂志,1996;37(11):663—664.
[17] 周叔平.浅淡震颤麻痹综合征与督脉的关系[J].新中医,1997;29(5):52.
[18] 朱士伏.老年性震颇麻痹辨治3则[J].新中医,1996;28(6):61.
[19] 黄俊山.震颇麻痹辨治体会[J].实用中西医结合杂志,1996;9(1):8—9.
[20] 凌玲.中医治疗震颤麻痹近况[J].陕西中医,2001;22(3):187—189.
[21] 宋秋云.帕金森病中医证治体会[J].河南中医,2003;23(3):47—48.
[22] 谭文澜.帕金森病中医证型与病程各期关系探讨[J].湖北中医杂志,2005;27(9):7—8.
[23] 李静,彭祥琴.针刺结合穴位埋线治疗震颤麻痹100例疗效观察[J].现代中西医 结合杂志,2002;11(2):179.
[24] 谢潇侠,口锁堂,蒲志宏,等.中医治疗震颤麻痹症综述[J].卫生职业教育,2005;23(3):110—113.
[25] 杨晓军.从中医角度探讨帕金森病.浙江中西医结合杂志[J].2003;13(2):88—108.
[26] 张秋娟,张云云,黄文燕.中医药治疗帕金森病的思路与方法[J].中西医结合学报,2004;2(1):75—77.
[27] 郑春叶,雒晓东,孙玉芝,等.中医辫证治疗帕金森病进展述评[J].新中医,2004;36(1):73—75.
[28] 周永红.中医治疗帕金森病切入点思考[J].中医药通报,2004;3(4):18—20.
[29] 马云枝,武继涛.帕金森病从脾论治[J].新中医,2004;36(1):3—4.
[30] 陈利国.针刺治疗震颤麻痹40例临床观察[J].中医杂志,1996;37(4):217.
[31] 赵国华.老年颤证分期治疗3法[J].中医杂志,1997;38(5):295.
[32] 符冰,伦新,荣莉,等.电针头穴及督脉穴治疗帕金森病:随机对照观察[J].中国临床康复,2004;8(4):4524—4525.
[33] 刘帅洲.穴位注射配合头针治疗震颤麻痹17例[J].吉林中医药,2001;(3):48.
[34] 蒋英.针刺治疗震颤性麻痹19例[J].四川中医,2000;18(9):56.
[35] 朱政.针灸结合中药对帕金森病康复治疗的疗效观察[J].现代康复,2001;5(11):125.
[36] 王顺,周振坤,胡丙成,等.头部电针透穴疗法治疗帕金森氏病的临床研究[J].中国针灸,2003,23(3):129.
[37] 周海东.头针加电针治疗帕金森病36例[J].四川中医,2004;22(4):88—89.
[38] 杨焱,陈红涛.头针治疗帕金森病30例的临床观察[J].JCAM,2004;20(6):36.
[39] 李小军.督脉穴为主治疗帕金森病临床分析[J].中国针灸,2003;23(8):445—446.
[40] 徐德隆,陈生弟,刘振国.帕金森病临床新技术[M].北京:人民军医出版社,2002,第1版:245—246.
[41] 王旭慧.针刺治疗帕金森病42例临床观察[J].实用中西医结合临床,2002;2(4):36—37.
[42] 郑翎,金宇.针刺治疗震颤麻痹52例临床观察[J].中国针灸,1998;18(2):79.
[43] 张海波,张召平,许继平.电针治疗帕金森病50例临床观察[J].中国中西医结合杂志,1995;(4):246.
[44] 施孝文.温针治疗帕金森氏症21例[J].中国针灸,2004,24(1):24.
[45] 周华青.针灸治疗帕金森病疗效观察[J].安徽临床杂志,2001;13(5):370.
[46] 王玲玲,何崇.针刺治疗帕金森病29例临床观察[J].中国针灸,1999;(12):709-711.
[47] 刘生百.不典型帕金森氏症案[J].中国针灸,2002;22(11):787.
[48] 何崇,邱茂良.针刺治疗血管性帕金森氏综合征9例临床观察[J].中国针灸,1998;(4):228.
[49] 王玲玲.帕金森病的针灸疗法[J].现代康复,2000;4(3):346—347.
[50] 程永德.帕金森病的针刺治疗[J].实用中西医结合杂志,1996;(6):114.
[51] 张乃钲,韩旭华.针药结合治疗震颤麻痹的临床观察[J].中国针灸,1996;16(12):11.
[52] 陈利国.针刺治疗震颤麻痹40例临床观察[J].中医杂志,1996;37(4):217.
[53] 金钰钧.矩阵针灸对震颤麻痹的康复医疗[J].针灸临床杂志,1998;14(3):5.
[54] Xu Ji-ping, Zhang Haibo, Zhang Zhaoping, et al. Clinical study of 50 cases of Parkinson disease treated with electroacupuncture[J]. Chinese Journal of Integrated Traditional and Western Medicine, 1996;2(2): 127.
[55] 张汗梁,祝维峰.针刺治疗帕金森病运动障碍的临床观察[J].中国针灸,2003,23(12):709.
[56] 陈兴华.针刺加直接灸治疗震颤麻痹30例临床观察[J].中医杂志,1999,40(6):342.
[57] 徐斌,马聘,王玲玲,等.穴位注射治疗实验性震颤麻痹的研究[J].针刺研究,1998;(1):49-51.
[58] 李静,彭祥琴.针刺结合穴位埋线治疗震颤麻痹100例疗效观察[J].现代中西医结合杂志,2002;11(2):179.
[59] 黄玉玲,王启芳.音乐电疗加头针治疗震颤麻痹30例[J].中国针灸,2002;22(9):641.
[60] 徐道祥,赵学英,罗和春.经络氧疗法治疗震颤麻痹35例临床观察[J].中国针灸,2000;(6):337—338.
[61] 李圣平.帕金森综合征的针灸康复疗法[J].四川中医,1993;11(9):51.
[62] 南柏红.电针加穴位注射治疗震颤性麻痹40例临床观察[J].黑龙江中医药,2001;6(6):51.
[63] Ungerstedt U. 6—hydroxydopamine induced degeneration of central monoamine neurons[J].Eur J Pharmacol, 1968;(5): 107.
[64] 罗海燕,彭国光.6—羟多巴胺帕金森病动物模型的研究[J].国外医学神经病学 神经外科学分册,1999;26(6):283—285.
[65] Chen SD, Xu DL, Yu HZ, et al. Study on MPTP-induced parkinsonian animal model in rhesus monkey and the mechanism of MPTP[J]. Chinese Medical Journal, 1998;101(12): 879.
[66] 王顺,周振坤,胡丙成,等.头部电针透穴疗法治疗帕金森氏病的临床研究[J].中国针灸,2003;23(3):129.
[67] 黄文燕.头针电刺激对震颤型帕金森病肌电图的影响[J].上海中医药大学学报,2000;14(3):18.
[68] 奚桂芳,蔡德亨,陈国美,等.头部穴位电刺激对帕金森病震颤肌电位的影响[J].上海针灸杂志,1996;(3):5.
[69] 王玲玲,何崇,刘跃光,等.针刺对帕金森病患者脑干诱发电位的影响[J].南京中医药大学学报,2000;16(4):229.
[70] 许继平,李玉莲,蔺新英,等.帕金森病患者血液抗氧化功能的变化及多巴制剂与VitE对其影响的研究[J].中风与神经疾病杂志,2000;26(1):56.
[71] 王红梅,罗德欣,王志平,等.帕金森病与自由基的生成和氧化的关系[J].中国临床康复,2002;(6):373.
[72] Simonian NA, Coyle JT. Oxidative stress in neurodegenerative disease [J]. Ann Rev Pharmacol Toxicol, 1996;(36): 83-106.
[73] Callio J, Oury TD, Chu CT. Manganese superoxide dismutase protectsagainst 6-droxydopamine injury in mouse brains[J]. Biol Chem, 2005:280(18): 18536-18542.
[74] 马骏,朱书秀.电针对帕金森病模型大鼠黑质抗氧化酶的影响[J].中国临床康复,2005;(9)5:120—121.
[75] 金泽,杨国梁,罗恩丽,等.针刺丘脑底核治疗帕金森病模型大鼠的实验研究[J].2003,20(6):46—47.
[76] 董晓彤,王双昆,任小群,等.针刺治疗震颤麻痹对患者血中LPO和SOD含量的影响[J].针刺研究,2001;26(1):28—31.
[77] Dethy S, Lame MA, Van Blercom N, et al. Microdialysis-HPLC for plasma levodopa and metabolites monitoring in parkinsonian patients[J]. Clirz Chem, 1997;43.
[78] 王丽敏,刘中霖,陶恩祥,等.帕金森病患者血浆单胺类神经递质的变化水平[J].中国临床康复,2005;9(5):60—61.
[79] Tohgi H, Abe T, Takahashi S, et al. Concentrations of serotonin and its related substances in the cerebrospinal fluid of parkinsonian patients and their relations to the severity of symptoms[J]. Nearo. sci Lett, 1993;(1500):71—4.
[80] 孙丹.帕金森病52例伴发抑郁的调查分析[J].中国临床康复.2003,7(13):986—8.
[81] Przedborski S, Jackson-Lewis V, Yodoyama R, et al. Role of neuronal nitric oxide 1-methy-4-phenyl-1,2,3,6—tetrahydropyridine (MPTP) induced dppaminergic neurotoxicity[J]. Proc. Natl. Acad. Sci. USA, 1996;93: 4565—4571.
[82] Kim T, Ischiropoulos Harry, Przedborski Serge. Nitric oxide and reactive oxygen species in Parkinson's disease[J]. IUBMB Life 2003;55(6) 329 —35.
[83] He Y, Imam Syed Z, Dong ZJ, et al. Role of nitric oxide in rotenoneinduced nigro-etriatal injury[J]. Neurochem 2003;86(6): 1338—45.
[84] ZhongCS, Soon AY. Biomedicine of Nitric Oxide[M]. Shanghai: Shanghai Yike Daxue Chubanshe 1997: 208.
[85] 雷革盛,苗建亭,李柱一.帕金森病血抗氧化酶系统变化及L-多巴的影响[J].中华神经免疫学和神经病学杂志,2002;9(3):172-176.
[86] 徐斌,马聘,陈国志.针刺调节原发性帕金森病脑脊液中单胺类递质临床观察[J].中国针灸,2002;22(3):183.
[87] 朱书秀,马骏.电针对帕金森病模型大鼠纹状体多巴胺及代谢产物的影响[J].江汉大学学报(自然科学版),2005;33(2):72—73.
[88] 梁希彬,刘贤宇,李丰桥,等.电针治疗部分损伤帕金森病大鼠的实验研究[J].针刺研究,2001;26(3):209.
[89] 马骏,田青,王彦青.电针对帕金森病大鼠纹状体谷氨酸含量的影响[J].上海针灸杂志,2003;22(1):36.
[90] 睢久红,奚桂芳,余爱珍.针刺结合复方中药治疗对帕金森病患者血浆中DA含量的影响[J].针刺研究,1997;22(1-2):106.
[91] 何崇,王玲玲,董洪涛,等.针灸对帕金森病大鼠模型脑内单胺类递质含量的影响[J].针刺研究,1998;23(1):44.
[92] 徐斌,马骋,陈国志.穴位注射对帕金森病中枢单胺类递质的影响[J].上海针灸杂志,2002;21(2):1.
[93] Bin Xu, Mei-Hong Shen, Guo-Zhi Chen. Effects of acupuncture and point-injection on central neuropeptide and nitric oxide in patients with primary Parkinson disease[J].Chinese Journal of Clinical Rehabilitation, 2004;8(34): 7858—7869.
[94] 马骏,田青,陈雄华,等.针刺对帕金森氏病模型大鼠NOS含量的影响[J].湖北 中医学院学报,2000;2(2):20—21.
[95] 叶民,董海蓉,丁新生.帕金森病的病因与发病机制研究进展[J].临床神经病学杂志,2002;15(1):57.
[96] Hvirsch EC, Mechanism and consequences of nerve cell death in Parkinson's disease[J]. Neural Transm Suppl, 1999;56 (4 Suppl 1): 127—127.
[97] Jenner P, Olanow CW. Understanding cell death in Parkinson's disease[J]. Ann Neurol, 1998;44 (Suppl 1): S72—S84.
[98] Jenner P, Dexter DT, Sian J, et al. Oxidative stress as a cause of nigral cell death in Parkinson' s disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson' s disease Research Group[J]. Ann Neurol, 1992;32(suppl);82—87.
[99] Zhang Y, Marcillat O, Giulivi C, et al. The oxidative inactivation of mitochondrial electron transport chain components and ATPase[J]. Biol Chem, 1990;265(27): 16330—16336.
[100] Ben-Shachar D, Zuk R, Glinka Y. Dopamine neurotoxicity: inhibition of mitochondrial respiration[J]. Ueurochem, 1995;64 (2): 718—723.
[101] 马骏,王华.电针帕金森模型大鼠对黑质TH含量的影响[J].针刺研究,2001;26(4):288.
[102] 梁希彬,刘贤宇,李丰桥,等.电针治疗部分损伤帕金森病大鼠的实验研究[J].针刺研究,2001,26(3):209.
[103] Liang XB, Luo Y, Liu XY, et al. Electro-acupuncture improves behavior and up-regulates GDNF mRNA in MFB transected rats[J]. Ueuroreport 2003;14(8): 1177.
[104] Liang XB, Liu XY, Li FQ, et al. Long-term high-frequency electro-acupuncture stimulation prevents neuronal degeneration and up-regulates BDNF mRNA in the substantia nigra and ventral tegmental area following medial forebrain bundle axotomy[J]. Brain Res Mol Brain Res 2002:108(1-2): 51.
[105] 马骏,王彦春,甘水咏.电针风府穴、太冲穴对PD大鼠黑质神经元凋亡的影响[J].湖北中医杂志,2003;25(11):5.
[106] 马骏,天青,王彦春,等.针刺对帕金森病模型大鼠纹状体的GLU含量的影响[J].上海针灸杂志,2003;22(1):36.
[107] Park HJ, Lim S, Joe ES, et al. Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson' s disease model[J]. Exp Neurol 2003;180(1):93.
[108] 唐勇,余曙光,陈瑾.电针促进帕金森小鼠黑质致密部突触形态可塑性的研究[J].成都中医药大学学报,2005;28(1):29—32.
[109] 朱文昕,奚桂芳,睢久红.针药治疗对帕金森病小鼠脑内多巴胺影响[J].针刺研究,1997;22(1—2):88.
[110] 罗明富,王志英,王平.电针对震颤麻痹大鼠中脑黑质和肾上腺髓质酪氨酸羟化酶的影响[J].针刺研究,1997;22(4):292.
[111] 杨泽洲,耿排力,汪如源,等.IL-1β、TNF-α和NO水平变化在某些神经系统疾病中的意义[J].西安医科大学学报,2001;22(1):43.
[112] Mogi M, Harada M, Kondo T, et al. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients[J]. Neurosci Lett, 1994;180: 147.
[113] LEWD, Rowe DB, Jankovic J, et al. Effects of cerebrospinal fluid from patients with Parkinson disease on dopam inergic cells[J]. Arch Neurol, 1999;56: 194.
[114] 孙业红,李东,王森,等.帕金森病治疗中的机制认识[J].中国临床康复,2003;7(5):792—3.
[115] Kluter H, Vieregge P, Stolzer H, et al. Defective production off interleukin-2 inpatients with idiopathic Parkinson disease[J]. Neurol Sci 1995;133(1—2): 134.
[116] Bessler H, Djaldetti R, Salman H, et al. IL-1 beta, IL-2, IL-6 and TNF-alpha production by peripheral blood mononuclear cells from patients with Parkinson disease[J]. Biomed Pharmacother 1999;53 (3): 141.
[117] 郑国庆,蔡业峰,黄燕,等.帕金森病的综合性治疗[J].中国临床康复,2002;6(15):2234.
[118] Bokor M, Fao A, Schnabel R, et al. Relationship between the immune system and the diseases of the central nervous system[J].Ther Hung 1992;40(2): 51.
[119] 李文昌,邓建中,慧敏,等.帕金森病患者36例免疫状态改变的分析[J].中国临床康复,2002;6(19):2992.
[120] 冼志红等,针刺对帕金森模型大鼠血清IL-1β及TNF-α的影响[J].国医论坛,2005,20(3):17—19.
[121] 骆仲达,陈兴华,唐纯志,等.针刺对帕金森病模型大鼠血液T淋巴细胞亚群的影响[J].中国临床康复,2004;8(10):1904—1905.
[122] 王维治.神经病学.[M],北京:人民卫生出版社,2001,第4版:206.
[123] Manyam B(1990). Paralysis agitans and levodopa in "Ayurveda": ancient Indian medical treatise[J].Mov Disord 5: 47—48.
[124] Parkinson J. An essay on the shaking palsy. 1817[J]. Neuropsychiatry Clin Ueurosci, 2002;14(2): 223-36.
[125] 陈生弟,徐德隆.帕金森病病因和发病机制研究进展[J].国外医学神经病学神经外科学分册,1997;24(5):243—247.
[126] 徐德隆,陈生弟,刘振国主编.帕金森病临床新技术[M],北京:人民军医出版社,2002,第1版:28.
[127] 孙斌.帕金森病的现代观(一)[J].解放军保健医学杂志,2005;7(1):50—51.
[128] Ehringer H, Hornykiewicz 0 (1960).Verteilung yon Noradrenalin und Dopamin(3-hydroxytyramin)im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems[J].Wien Klin Wschr 38: 1236—1239.
[129] Tanner CM, Chen B, Wang WZ, et al. Environmental factors and Parkinson's disease: a case control study in China[J].Neurology, 1989;(39): 660—664.
[130] Burns RS, LeWitt PA, Ebert MH, et al. The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) [J]. N Engl J Med, 1985;312(22): 1418—1421.
[131] Cleeter MW, Cooper JM, Schapira AH. Irreversible inhibition of mitochondrial complex I by 1-methy-4-phenylpyridin: evidence for free radical involvement[J]. Neurochem, 1992;58(2): 786—789.
[132] Francesca Vaglini, Carla Pardini, Cristina Viaggi, et al. Cytochrome P450 and Parkinsonism:Protective role of CYP2E1[J].Funct Neurol 2001;16(suppl): 107—112.
[133] Agunder JA, Jimenez-Jimemez FJ, Luengo A, et al. Slow all otypic variants of the NAT2 gene and susceptibility to early-oneset Parkinson disease[J].Neurology, 1998;51(6): 1587—1592.
[134] Chan DK, Lam MK, Wong R. Strong association between N-acetyltxans-fexase 2 genotype and PD in Hong Kong Chinese[J].Neurology, 2003;60(6): 1002-1005.
[135] 洪雁,张本恕.N-乙酰基转移酶基囚多态性与帕金森病遗传易患性关系的研究[J].中华神经外科杂志,2002;18(1):30—33.
[136] Li H, He Z, Su T, et al. Protective action of recombinant neurturin on dopaminergic neurons in substantia nigra in a rhesus monkey model of Parkinson's disease[J]. Neurol Res 2003;25(3): 263—7.
[137] Fialova M, Seveikova S, Smarda J, et al. Determination of optimal conditions for detection of acute myeloid leukemiat (8;21) and t (15;17) translocations using RT-PCR[J]. Neoplasma 2002;49 (1): 33—7.
[138] G.R. Uhl, R.W. row. The Burden of Complex Genetics in Brain Disorders[J].Arch Gen Psychiatry 2004;61(3): 223—229.
[139] Engelender S, Wanner T, Kleiderlein JJ, et al. Organization of the human synphilin-1 gene, a candidate for Parkinson's disease[J].Mamm Genome 2000;11(9): 763—6.
[140] Sofic E, Lange KW, Jellinger K, et al. Reduced and oxidized glutathine in the substantia nigra of patients with Parkinson's disease[J]. Neurosic Lett, 1992;142(2): 128—130.
[141] Gorman AM, McGowan A, O Nell C, et al. Oxidative stress and apoptosis in neurodegeneration[J].Neurol sci, 1996;139 (suppl):45-52.
[142] Schapirs AHV. Mitochondrial dysfunction and oxidative damage in Parkinson's disease[J].In: Mitochondrial and Free Radicals in Neurodegenerative Diseases, Beal MF, Howell N, Bodis-Wollner I,Wiley-liss, 1997: 343—359.
[143] Ruberg M, Scherman D, Javoy-Agid F, et al. Dopamine denervation, age of onset, and Parkinson's disease[J].Neurology 1995;45(2): 392.
[144] Fiszer U, Piotrowska K, Korlak J, et al. The immunological status in Parkinson's disease[J].Med Lab Sci, 1991;48(3): 196—200.
[145] Abramsky O, Litvin Y. Automimmune response to dopaminereceptor as a possible mechanism in the pathogenesis of Parkinson's disease and schizophrenia[J].Perspect Biol Med, 1978;22(1): 104—114.
[146] Pocock JM, Liddle AC. Microglial signalling cascades in neurodegenerative disease[J].Prog Brain Res, 2001;132: 555—565.
[147] Pozzoli G, Mancuso C, MirtellaAet al. Carbon monoxide as a novel neuroendocrine modulator: inhibition of stimulated corticotropinrel—easing hormone release from acute rat hypothalamic explants[J]. Endocrinology,1994;135(6):2314—2317.
[148] 周义先等.中西医治疗帕金森病概况[J].安徽中医学院学报,2005;24(3):59—61.
[149] Alllain H. Parkinson's discase: the treatment options[J].BMJ, 1999: 319:141.
[150] Olanow CW. Attempts to obtain neuroprateetion in Parkinson's disease[J]. Neurology, 1997, 49(suppl 1):S20.
[151] Power W. The role of COMT inhibition the freatment of Parkinson's disease[J]. Neurology, 2004, 62(suppl 1): S33.
[152] Rabsse da X. Perperctive in the treatment of Parkinson's disease: COMT intribifors open up new treatment strategies[J].Drugs of Today, 1999, 35(9):701.
[153] Rinne UK, Bracco F, Chouza C, et al. Cabergoline in the treatment of early Parkinson' s disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa[J]. Neurology, 1997;48(2): 363—368.
[154] 徐德隆,陈生弟,刘振国主编.帕金森病临床新技术[M],北京:人民军医出版社,2002,第1版:246—253.
[155] 包新民,舒斯云.大鼠脑立体定向图谱[M].北京:人民卫生出版社,1991:49—58.
[156] 周厚广,陆建明,鲍远程,等.6-羟基多巴胺帕金森病大鼠模型的建立与评价[J].中国行为医学科学,2002;11(1):4—7.
[157] 肖春苟,郭国庆,沈伟哉,等.6-羟基多巴胺两点注射法建立帕金森病模型大鼠的行为学与组织病理学特征[J].中国临床康复,2005,9(1):56—57.
[158] 李忠仁主编.实验针灸学[M].北京:中国中医药出版社,2003,第1版:327—328.
[159] 曹非,孙圣刚,童萼塘,等.帕金森病大鼠行为与黑质形态学变化的相关性研究[J].中国老年学杂志,2003;23(2):111—3.
[160] Thomas J, Wang J, Takubo H, et al. A 6-DHDA-induced selective parkinsonian rat model: Further biochemical and behavioral characterization[J].Exp Neural 1994;126: 159.
[2] 王克勤.震额麻痹的中医治疗[J].中医药研究,1991;(2):35.
[3] 李庚和.中医为主治疗震颤麻痹症50例临床分析[J].上海中医药杂志,1992;(2):12.
[4] 刘明武.震额麻痹辩治探幽[J].辽宁中医杂志,1997;(24):491.
[5] 王永炎,李明富,戴锡孟,等编.中医内科学[M],上海:上海科学技术出版社,1994,第6版:370.
[6] 王亚丽.颤证的病因病机探讨[J].陕西中医学院学报,1998;21(3):5.
[7] 朱红梅.震颤麻痹的病理探析[J].厦门大学学报·自然科学版,2000;(64):556-559.
[8] 邹忆怀.王永炎教授治疗颤振病(帕金森氏病)经验探讨[J].北京中医药大学学报,1996;(19):15.
[9] 隆呈祥.老年颤证(帕金森病)的中医研究回顾与展望[J].中国中医药信息杂志,2000;7(10):10—12.
[10] 武继涛.震颤麻痹从脾论治[J].浙江中医杂志,2003;38(9):399.
[11] 王一德.帕金森综合征的中医辨治[J].安徽中医学院学报,1997;16(3):42—43.
[12] 何建成.帕金森病中医药治疗的再思考——兼谈“滋肾平肝,化痰活血,解毒散结”是帕金森病的基本治疗法则[J].中医药通报,2005;4(1):12—14.
[13] 老膺荣,朱泉.帕金森氏病中医思辨[J].辽宁中医杂志,2005;32(10):1015—1016.
[14] 董洪涛.《内经》对颤症的认识[J].国医论坛,1998;13(3):17.
[15] 邢诒刚,陶恩祥.帕金森病[M],广州:广东高等教育出版社,1988,74.
[16] 樊銮.周仲英治疗震颤麻痹的经验[J].中医杂志,1996;37(11):663—664.
[17] 周叔平.浅淡震颤麻痹综合征与督脉的关系[J].新中医,1997;29(5):52.
[18] 朱士伏.老年性震颇麻痹辨治3则[J].新中医,1996;28(6):61.
[19] 黄俊山.震颇麻痹辨治体会[J].实用中西医结合杂志,1996;9(1):8—9.
[20] 凌玲.中医治疗震颤麻痹近况[J].陕西中医,2001;22(3):187—189.
[21] 宋秋云.帕金森病中医证治体会[J].河南中医,2003;23(3):47—48.
[22] 谭文澜.帕金森病中医证型与病程各期关系探讨[J].湖北中医杂志,2005;27(9):7—8.
[23] 李静,彭祥琴.针刺结合穴位埋线治疗震颤麻痹100例疗效观察[J].现代中西医 结合杂志,2002;11(2):179.
[24] 谢潇侠,口锁堂,蒲志宏,等.中医治疗震颤麻痹症综述[J].卫生职业教育,2005;23(3):110—113.
[25] 杨晓军.从中医角度探讨帕金森病.浙江中西医结合杂志[J].2003;13(2):88—108.
[26] 张秋娟,张云云,黄文燕.中医药治疗帕金森病的思路与方法[J].中西医结合学报,2004;2(1):75—77.
[27] 郑春叶,雒晓东,孙玉芝,等.中医辫证治疗帕金森病进展述评[J].新中医,2004;36(1):73—75.
[28] 周永红.中医治疗帕金森病切入点思考[J].中医药通报,2004;3(4):18—20.
[29] 马云枝,武继涛.帕金森病从脾论治[J].新中医,2004;36(1):3—4.
[30] 陈利国.针刺治疗震颤麻痹40例临床观察[J].中医杂志,1996;37(4):217.
[31] 赵国华.老年颤证分期治疗3法[J].中医杂志,1997;38(5):295.
[32] 符冰,伦新,荣莉,等.电针头穴及督脉穴治疗帕金森病:随机对照观察[J].中国临床康复,2004;8(4):4524—4525.
[33] 刘帅洲.穴位注射配合头针治疗震颤麻痹17例[J].吉林中医药,2001;(3):48.
[34] 蒋英.针刺治疗震颤性麻痹19例[J].四川中医,2000;18(9):56.
[35] 朱政.针灸结合中药对帕金森病康复治疗的疗效观察[J].现代康复,2001;5(11):125.
[36] 王顺,周振坤,胡丙成,等.头部电针透穴疗法治疗帕金森氏病的临床研究[J].中国针灸,2003,23(3):129.
[37] 周海东.头针加电针治疗帕金森病36例[J].四川中医,2004;22(4):88—89.
[38] 杨焱,陈红涛.头针治疗帕金森病30例的临床观察[J].JCAM,2004;20(6):36.
[39] 李小军.督脉穴为主治疗帕金森病临床分析[J].中国针灸,2003;23(8):445—446.
[40] 徐德隆,陈生弟,刘振国.帕金森病临床新技术[M].北京:人民军医出版社,2002,第1版:245—246.
[41] 王旭慧.针刺治疗帕金森病42例临床观察[J].实用中西医结合临床,2002;2(4):36—37.
[42] 郑翎,金宇.针刺治疗震颤麻痹52例临床观察[J].中国针灸,1998;18(2):79.
[43] 张海波,张召平,许继平.电针治疗帕金森病50例临床观察[J].中国中西医结合杂志,1995;(4):246.
[44] 施孝文.温针治疗帕金森氏症21例[J].中国针灸,2004,24(1):24.
[45] 周华青.针灸治疗帕金森病疗效观察[J].安徽临床杂志,2001;13(5):370.
[46] 王玲玲,何崇.针刺治疗帕金森病29例临床观察[J].中国针灸,1999;(12):709-711.
[47] 刘生百.不典型帕金森氏症案[J].中国针灸,2002;22(11):787.
[48] 何崇,邱茂良.针刺治疗血管性帕金森氏综合征9例临床观察[J].中国针灸,1998;(4):228.
[49] 王玲玲.帕金森病的针灸疗法[J].现代康复,2000;4(3):346—347.
[50] 程永德.帕金森病的针刺治疗[J].实用中西医结合杂志,1996;(6):114.
[51] 张乃钲,韩旭华.针药结合治疗震颤麻痹的临床观察[J].中国针灸,1996;16(12):11.
[52] 陈利国.针刺治疗震颤麻痹40例临床观察[J].中医杂志,1996;37(4):217.
[53] 金钰钧.矩阵针灸对震颤麻痹的康复医疗[J].针灸临床杂志,1998;14(3):5.
[54] Xu Ji-ping, Zhang Haibo, Zhang Zhaoping, et al. Clinical study of 50 cases of Parkinson disease treated with electroacupuncture[J]. Chinese Journal of Integrated Traditional and Western Medicine, 1996;2(2): 127.
[55] 张汗梁,祝维峰.针刺治疗帕金森病运动障碍的临床观察[J].中国针灸,2003,23(12):709.
[56] 陈兴华.针刺加直接灸治疗震颤麻痹30例临床观察[J].中医杂志,1999,40(6):342.
[57] 徐斌,马聘,王玲玲,等.穴位注射治疗实验性震颤麻痹的研究[J].针刺研究,1998;(1):49-51.
[58] 李静,彭祥琴.针刺结合穴位埋线治疗震颤麻痹100例疗效观察[J].现代中西医结合杂志,2002;11(2):179.
[59] 黄玉玲,王启芳.音乐电疗加头针治疗震颤麻痹30例[J].中国针灸,2002;22(9):641.
[60] 徐道祥,赵学英,罗和春.经络氧疗法治疗震颤麻痹35例临床观察[J].中国针灸,2000;(6):337—338.
[61] 李圣平.帕金森综合征的针灸康复疗法[J].四川中医,1993;11(9):51.
[62] 南柏红.电针加穴位注射治疗震颤性麻痹40例临床观察[J].黑龙江中医药,2001;6(6):51.
[63] Ungerstedt U. 6—hydroxydopamine induced degeneration of central monoamine neurons[J].Eur J Pharmacol, 1968;(5): 107.
[64] 罗海燕,彭国光.6—羟多巴胺帕金森病动物模型的研究[J].国外医学神经病学 神经外科学分册,1999;26(6):283—285.
[65] Chen SD, Xu DL, Yu HZ, et al. Study on MPTP-induced parkinsonian animal model in rhesus monkey and the mechanism of MPTP[J]. Chinese Medical Journal, 1998;101(12): 879.
[66] 王顺,周振坤,胡丙成,等.头部电针透穴疗法治疗帕金森氏病的临床研究[J].中国针灸,2003;23(3):129.
[67] 黄文燕.头针电刺激对震颤型帕金森病肌电图的影响[J].上海中医药大学学报,2000;14(3):18.
[68] 奚桂芳,蔡德亨,陈国美,等.头部穴位电刺激对帕金森病震颤肌电位的影响[J].上海针灸杂志,1996;(3):5.
[69] 王玲玲,何崇,刘跃光,等.针刺对帕金森病患者脑干诱发电位的影响[J].南京中医药大学学报,2000;16(4):229.
[70] 许继平,李玉莲,蔺新英,等.帕金森病患者血液抗氧化功能的变化及多巴制剂与VitE对其影响的研究[J].中风与神经疾病杂志,2000;26(1):56.
[71] 王红梅,罗德欣,王志平,等.帕金森病与自由基的生成和氧化的关系[J].中国临床康复,2002;(6):373.
[72] Simonian NA, Coyle JT. Oxidative stress in neurodegenerative disease [J]. Ann Rev Pharmacol Toxicol, 1996;(36): 83-106.
[73] Callio J, Oury TD, Chu CT. Manganese superoxide dismutase protectsagainst 6-droxydopamine injury in mouse brains[J]. Biol Chem, 2005:280(18): 18536-18542.
[74] 马骏,朱书秀.电针对帕金森病模型大鼠黑质抗氧化酶的影响[J].中国临床康复,2005;(9)5:120—121.
[75] 金泽,杨国梁,罗恩丽,等.针刺丘脑底核治疗帕金森病模型大鼠的实验研究[J].2003,20(6):46—47.
[76] 董晓彤,王双昆,任小群,等.针刺治疗震颤麻痹对患者血中LPO和SOD含量的影响[J].针刺研究,2001;26(1):28—31.
[77] Dethy S, Lame MA, Van Blercom N, et al. Microdialysis-HPLC for plasma levodopa and metabolites monitoring in parkinsonian patients[J]. Clirz Chem, 1997;43.
[78] 王丽敏,刘中霖,陶恩祥,等.帕金森病患者血浆单胺类神经递质的变化水平[J].中国临床康复,2005;9(5):60—61.
[79] Tohgi H, Abe T, Takahashi S, et al. Concentrations of serotonin and its related substances in the cerebrospinal fluid of parkinsonian patients and their relations to the severity of symptoms[J]. Nearo. sci Lett, 1993;(1500):71—4.
[80] 孙丹.帕金森病52例伴发抑郁的调查分析[J].中国临床康复.2003,7(13):986—8.
[81] Przedborski S, Jackson-Lewis V, Yodoyama R, et al. Role of neuronal nitric oxide 1-methy-4-phenyl-1,2,3,6—tetrahydropyridine (MPTP) induced dppaminergic neurotoxicity[J]. Proc. Natl. Acad. Sci. USA, 1996;93: 4565—4571.
[82] Kim T, Ischiropoulos Harry, Przedborski Serge. Nitric oxide and reactive oxygen species in Parkinson's disease[J]. IUBMB Life 2003;55(6) 329 —35.
[83] He Y, Imam Syed Z, Dong ZJ, et al. Role of nitric oxide in rotenoneinduced nigro-etriatal injury[J]. Neurochem 2003;86(6): 1338—45.
[84] ZhongCS, Soon AY. Biomedicine of Nitric Oxide[M]. Shanghai: Shanghai Yike Daxue Chubanshe 1997: 208.
[85] 雷革盛,苗建亭,李柱一.帕金森病血抗氧化酶系统变化及L-多巴的影响[J].中华神经免疫学和神经病学杂志,2002;9(3):172-176.
[86] 徐斌,马聘,陈国志.针刺调节原发性帕金森病脑脊液中单胺类递质临床观察[J].中国针灸,2002;22(3):183.
[87] 朱书秀,马骏.电针对帕金森病模型大鼠纹状体多巴胺及代谢产物的影响[J].江汉大学学报(自然科学版),2005;33(2):72—73.
[88] 梁希彬,刘贤宇,李丰桥,等.电针治疗部分损伤帕金森病大鼠的实验研究[J].针刺研究,2001;26(3):209.
[89] 马骏,田青,王彦青.电针对帕金森病大鼠纹状体谷氨酸含量的影响[J].上海针灸杂志,2003;22(1):36.
[90] 睢久红,奚桂芳,余爱珍.针刺结合复方中药治疗对帕金森病患者血浆中DA含量的影响[J].针刺研究,1997;22(1-2):106.
[91] 何崇,王玲玲,董洪涛,等.针灸对帕金森病大鼠模型脑内单胺类递质含量的影响[J].针刺研究,1998;23(1):44.
[92] 徐斌,马骋,陈国志.穴位注射对帕金森病中枢单胺类递质的影响[J].上海针灸杂志,2002;21(2):1.
[93] Bin Xu, Mei-Hong Shen, Guo-Zhi Chen. Effects of acupuncture and point-injection on central neuropeptide and nitric oxide in patients with primary Parkinson disease[J].Chinese Journal of Clinical Rehabilitation, 2004;8(34): 7858—7869.
[94] 马骏,田青,陈雄华,等.针刺对帕金森氏病模型大鼠NOS含量的影响[J].湖北 中医学院学报,2000;2(2):20—21.
[95] 叶民,董海蓉,丁新生.帕金森病的病因与发病机制研究进展[J].临床神经病学杂志,2002;15(1):57.
[96] Hvirsch EC, Mechanism and consequences of nerve cell death in Parkinson's disease[J]. Neural Transm Suppl, 1999;56 (4 Suppl 1): 127—127.
[97] Jenner P, Olanow CW. Understanding cell death in Parkinson's disease[J]. Ann Neurol, 1998;44 (Suppl 1): S72—S84.
[98] Jenner P, Dexter DT, Sian J, et al. Oxidative stress as a cause of nigral cell death in Parkinson' s disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson' s disease Research Group[J]. Ann Neurol, 1992;32(suppl);82—87.
[99] Zhang Y, Marcillat O, Giulivi C, et al. The oxidative inactivation of mitochondrial electron transport chain components and ATPase[J]. Biol Chem, 1990;265(27): 16330—16336.
[100] Ben-Shachar D, Zuk R, Glinka Y. Dopamine neurotoxicity: inhibition of mitochondrial respiration[J]. Ueurochem, 1995;64 (2): 718—723.
[101] 马骏,王华.电针帕金森模型大鼠对黑质TH含量的影响[J].针刺研究,2001;26(4):288.
[102] 梁希彬,刘贤宇,李丰桥,等.电针治疗部分损伤帕金森病大鼠的实验研究[J].针刺研究,2001,26(3):209.
[103] Liang XB, Luo Y, Liu XY, et al. Electro-acupuncture improves behavior and up-regulates GDNF mRNA in MFB transected rats[J]. Ueuroreport 2003;14(8): 1177.
[104] Liang XB, Liu XY, Li FQ, et al. Long-term high-frequency electro-acupuncture stimulation prevents neuronal degeneration and up-regulates BDNF mRNA in the substantia nigra and ventral tegmental area following medial forebrain bundle axotomy[J]. Brain Res Mol Brain Res 2002:108(1-2): 51.
[105] 马骏,王彦春,甘水咏.电针风府穴、太冲穴对PD大鼠黑质神经元凋亡的影响[J].湖北中医杂志,2003;25(11):5.
[106] 马骏,天青,王彦春,等.针刺对帕金森病模型大鼠纹状体的GLU含量的影响[J].上海针灸杂志,2003;22(1):36.
[107] Park HJ, Lim S, Joe ES, et al. Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson' s disease model[J]. Exp Neurol 2003;180(1):93.
[108] 唐勇,余曙光,陈瑾.电针促进帕金森小鼠黑质致密部突触形态可塑性的研究[J].成都中医药大学学报,2005;28(1):29—32.
[109] 朱文昕,奚桂芳,睢久红.针药治疗对帕金森病小鼠脑内多巴胺影响[J].针刺研究,1997;22(1—2):88.
[110] 罗明富,王志英,王平.电针对震颤麻痹大鼠中脑黑质和肾上腺髓质酪氨酸羟化酶的影响[J].针刺研究,1997;22(4):292.
[111] 杨泽洲,耿排力,汪如源,等.IL-1β、TNF-α和NO水平变化在某些神经系统疾病中的意义[J].西安医科大学学报,2001;22(1):43.
[112] Mogi M, Harada M, Kondo T, et al. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients[J]. Neurosci Lett, 1994;180: 147.
[113] LEWD, Rowe DB, Jankovic J, et al. Effects of cerebrospinal fluid from patients with Parkinson disease on dopam inergic cells[J]. Arch Neurol, 1999;56: 194.
[114] 孙业红,李东,王森,等.帕金森病治疗中的机制认识[J].中国临床康复,2003;7(5):792—3.
[115] Kluter H, Vieregge P, Stolzer H, et al. Defective production off interleukin-2 inpatients with idiopathic Parkinson disease[J]. Neurol Sci 1995;133(1—2): 134.
[116] Bessler H, Djaldetti R, Salman H, et al. IL-1 beta, IL-2, IL-6 and TNF-alpha production by peripheral blood mononuclear cells from patients with Parkinson disease[J]. Biomed Pharmacother 1999;53 (3): 141.
[117] 郑国庆,蔡业峰,黄燕,等.帕金森病的综合性治疗[J].中国临床康复,2002;6(15):2234.
[118] Bokor M, Fao A, Schnabel R, et al. Relationship between the immune system and the diseases of the central nervous system[J].Ther Hung 1992;40(2): 51.
[119] 李文昌,邓建中,慧敏,等.帕金森病患者36例免疫状态改变的分析[J].中国临床康复,2002;6(19):2992.
[120] 冼志红等,针刺对帕金森模型大鼠血清IL-1β及TNF-α的影响[J].国医论坛,2005,20(3):17—19.
[121] 骆仲达,陈兴华,唐纯志,等.针刺对帕金森病模型大鼠血液T淋巴细胞亚群的影响[J].中国临床康复,2004;8(10):1904—1905.
[122] 王维治.神经病学.[M],北京:人民卫生出版社,2001,第4版:206.
[123] Manyam B(1990). Paralysis agitans and levodopa in "Ayurveda": ancient Indian medical treatise[J].Mov Disord 5: 47—48.
[124] Parkinson J. An essay on the shaking palsy. 1817[J]. Neuropsychiatry Clin Ueurosci, 2002;14(2): 223-36.
[125] 陈生弟,徐德隆.帕金森病病因和发病机制研究进展[J].国外医学神经病学神经外科学分册,1997;24(5):243—247.
[126] 徐德隆,陈生弟,刘振国主编.帕金森病临床新技术[M],北京:人民军医出版社,2002,第1版:28.
[127] 孙斌.帕金森病的现代观(一)[J].解放军保健医学杂志,2005;7(1):50—51.
[128] Ehringer H, Hornykiewicz 0 (1960).Verteilung yon Noradrenalin und Dopamin(3-hydroxytyramin)im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems[J].Wien Klin Wschr 38: 1236—1239.
[129] Tanner CM, Chen B, Wang WZ, et al. Environmental factors and Parkinson's disease: a case control study in China[J].Neurology, 1989;(39): 660—664.
[130] Burns RS, LeWitt PA, Ebert MH, et al. The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) [J]. N Engl J Med, 1985;312(22): 1418—1421.
[131] Cleeter MW, Cooper JM, Schapira AH. Irreversible inhibition of mitochondrial complex I by 1-methy-4-phenylpyridin: evidence for free radical involvement[J]. Neurochem, 1992;58(2): 786—789.
[132] Francesca Vaglini, Carla Pardini, Cristina Viaggi, et al. Cytochrome P450 and Parkinsonism:Protective role of CYP2E1[J].Funct Neurol 2001;16(suppl): 107—112.
[133] Agunder JA, Jimenez-Jimemez FJ, Luengo A, et al. Slow all otypic variants of the NAT2 gene and susceptibility to early-oneset Parkinson disease[J].Neurology, 1998;51(6): 1587—1592.
[134] Chan DK, Lam MK, Wong R. Strong association between N-acetyltxans-fexase 2 genotype and PD in Hong Kong Chinese[J].Neurology, 2003;60(6): 1002-1005.
[135] 洪雁,张本恕.N-乙酰基转移酶基囚多态性与帕金森病遗传易患性关系的研究[J].中华神经外科杂志,2002;18(1):30—33.
[136] Li H, He Z, Su T, et al. Protective action of recombinant neurturin on dopaminergic neurons in substantia nigra in a rhesus monkey model of Parkinson's disease[J]. Neurol Res 2003;25(3): 263—7.
[137] Fialova M, Seveikova S, Smarda J, et al. Determination of optimal conditions for detection of acute myeloid leukemiat (8;21) and t (15;17) translocations using RT-PCR[J]. Neoplasma 2002;49 (1): 33—7.
[138] G.R. Uhl, R.W. row. The Burden of Complex Genetics in Brain Disorders[J].Arch Gen Psychiatry 2004;61(3): 223—229.
[139] Engelender S, Wanner T, Kleiderlein JJ, et al. Organization of the human synphilin-1 gene, a candidate for Parkinson's disease[J].Mamm Genome 2000;11(9): 763—6.
[140] Sofic E, Lange KW, Jellinger K, et al. Reduced and oxidized glutathine in the substantia nigra of patients with Parkinson's disease[J]. Neurosic Lett, 1992;142(2): 128—130.
[141] Gorman AM, McGowan A, O Nell C, et al. Oxidative stress and apoptosis in neurodegeneration[J].Neurol sci, 1996;139 (suppl):45-52.
[142] Schapirs AHV. Mitochondrial dysfunction and oxidative damage in Parkinson's disease[J].In: Mitochondrial and Free Radicals in Neurodegenerative Diseases, Beal MF, Howell N, Bodis-Wollner I,Wiley-liss, 1997: 343—359.
[143] Ruberg M, Scherman D, Javoy-Agid F, et al. Dopamine denervation, age of onset, and Parkinson's disease[J].Neurology 1995;45(2): 392.
[144] Fiszer U, Piotrowska K, Korlak J, et al. The immunological status in Parkinson's disease[J].Med Lab Sci, 1991;48(3): 196—200.
[145] Abramsky O, Litvin Y. Automimmune response to dopaminereceptor as a possible mechanism in the pathogenesis of Parkinson's disease and schizophrenia[J].Perspect Biol Med, 1978;22(1): 104—114.
[146] Pocock JM, Liddle AC. Microglial signalling cascades in neurodegenerative disease[J].Prog Brain Res, 2001;132: 555—565.
[147] Pozzoli G, Mancuso C, MirtellaAet al. Carbon monoxide as a novel neuroendocrine modulator: inhibition of stimulated corticotropinrel—easing hormone release from acute rat hypothalamic explants[J]. Endocrinology,1994;135(6):2314—2317.
[148] 周义先等.中西医治疗帕金森病概况[J].安徽中医学院学报,2005;24(3):59—61.
[149] Alllain H. Parkinson's discase: the treatment options[J].BMJ, 1999: 319:141.
[150] Olanow CW. Attempts to obtain neuroprateetion in Parkinson's disease[J]. Neurology, 1997, 49(suppl 1):S20.
[151] Power W. The role of COMT inhibition the freatment of Parkinson's disease[J]. Neurology, 2004, 62(suppl 1): S33.
[152] Rabsse da X. Perperctive in the treatment of Parkinson's disease: COMT intribifors open up new treatment strategies[J].Drugs of Today, 1999, 35(9):701.
[153] Rinne UK, Bracco F, Chouza C, et al. Cabergoline in the treatment of early Parkinson' s disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa[J]. Neurology, 1997;48(2): 363—368.
[154] 徐德隆,陈生弟,刘振国主编.帕金森病临床新技术[M],北京:人民军医出版社,2002,第1版:246—253.
[155] 包新民,舒斯云.大鼠脑立体定向图谱[M].北京:人民卫生出版社,1991:49—58.
[156] 周厚广,陆建明,鲍远程,等.6-羟基多巴胺帕金森病大鼠模型的建立与评价[J].中国行为医学科学,2002;11(1):4—7.
[157] 肖春苟,郭国庆,沈伟哉,等.6-羟基多巴胺两点注射法建立帕金森病模型大鼠的行为学与组织病理学特征[J].中国临床康复,2005,9(1):56—57.
[158] 李忠仁主编.实验针灸学[M].北京:中国中医药出版社,2003,第1版:327—328.
[159] 曹非,孙圣刚,童萼塘,等.帕金森病大鼠行为与黑质形态学变化的相关性研究[J].中国老年学杂志,2003;23(2):111—3.
[160] Thomas J, Wang J, Takubo H, et al. A 6-DHDA-induced selective parkinsonian rat model: Further biochemical and behavioral characterization[J].Exp Neural 1994;126: 159.